Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Bleeding Risk After Anticoagulant Therapy for Atrial Fibrillation Based on Proteomics and Metabolomics

NCT05181774 is registered in ClinicalTrials.gov with Yue LI as lead sponsor.

NCT NCT05181774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05181774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Bleeding Risk After Anticoagulant Therapy for Atrial Fibrillation Based on Proteomics and Metabolomics
Lead sponsor
Yue LI
Phase
Observational
Overall status
Unknown status
Start date
December 20, 2021
Completion date
December 31, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant therapy, atrial fibrillation, bleeding